Weihai Baihe Biology Technological Co., Ltd. (SHA:603102)
China · Delayed Price · Currency is CNY 36.86
+0.15 (0.41%)
At close: May 29, 2026
SHA:603102 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 122.13 | 128.43 | 139.31 | 169.07 | 137.84 | 148.04 |
Depreciation & Amortization | 45.88 | 45.88 | 41.17 | 37.56 | 33.12 | 23.76 |
Other Amortization | 1.73 | 1.73 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | - | -0.14 | -0.06 | -0.27 | 0 |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0.01 | 0.34 | 5.66 | 4.22 |
Loss (Gain) From Sale of Investments | -1.05 | -1.05 | -1.26 | -1.11 | -0.42 | - |
Provision & Write-off of Bad Debts | 0.3 | 0.3 | 1.26 | 0.14 | 0.37 | 1 |
Other Operating Activities | -28.92 | 5.02 | -11.59 | -9.8 | -15.11 | -0.41 |
Change in Accounts Receivable | -0.72 | -0.72 | -52.14 | -8.93 | -22.86 | -10.4 |
Change in Inventory | -6.9 | -6.9 | 6.4 | 16.92 | -41 | -31.59 |
Change in Accounts Payable | 14.5 | 14.5 | 4.31 | -10.19 | 55.82 | 34.21 |
Operating Cash Flow | 145.78 | 186.02 | 127.65 | 193.85 | 152.91 | 169.15 |
Operating Cash Flow Growth | -4.66% | 45.73% | -34.15% | 26.78% | -9.60% | 12.77% |
Capital Expenditures | -47.03 | -55.66 | -94.92 | -96.52 | -51.54 | -124.55 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.28 | 0.25 | 0.61 | 0 |
Cash Acquisitions | -58.41 | -58.41 | - | - | - | - |
Divestitures | - | - | - | 0.09 | 0.08 | - |
Investment in Securities | - | -10 | - | - | - | - |
Other Investing Activities | 12.6 | 14.36 | 14.75 | 15.5 | 8.91 | 1.71 |
Investing Cash Flow | -92.82 | -109.7 | -79.89 | -80.68 | -41.95 | -122.83 |
Long-Term Debt Repaid | - | -2.1 | -2.18 | -1.37 | -2.62 | -1.29 |
Net Debt Issued (Repaid) | -2.1 | -2.1 | -2.18 | -1.37 | -2.62 | -1.29 |
Issuance of Common Stock | - | - | - | - | 616.06 | - |
Repurchase of Common Stock | -30.03 | -30.03 | -0.61 | -38.25 | - | - |
Common Dividends Paid | -46.71 | -46.71 | -47.23 | -38.4 | -32 | -14.4 |
Other Financing Activities | 1.44 | 4.75 | - | - | -13.56 | - |
Financing Cash Flow | -77.39 | -74.08 | -50.02 | -78.02 | 567.87 | -15.69 |
Foreign Exchange Rate Adjustments | -5.24 | -3.13 | 1.26 | 0.79 | 6.67 | -1.15 |
Net Cash Flow | -29.66 | -0.88 | -1 | 35.95 | 685.5 | 29.48 |
Free Cash Flow | 98.75 | 130.36 | 32.73 | 97.33 | 101.36 | 44.6 |
Free Cash Flow Growth | 62.77% | 298.29% | -66.37% | -3.98% | 127.25% | -61.56% |
Free Cash Flow Margin | 10.33% | 14.31% | 4.08% | 11.17% | 13.98% | 6.74% |
Free Cash Flow Per Share | 1.58 | 2.08 | 0.51 | 1.52 | 1.62 | 0.93 |
Cash Income Tax Paid | 65.17 | 59.17 | 58.8 | 64.38 | 41.51 | 55.42 |
Levered Free Cash Flow | 35.62 | 67.58 | -1.27 | 50.33 | 52.33 | 14.38 |
Unlevered Free Cash Flow | 35.9 | 67.77 | -1.22 | 50.39 | 52.41 | 14.48 |
Change in Working Capital | 5.7 | 5.7 | -41.11 | -2.28 | -8.29 | -7.45 |